Shopping Cart
- Remove All
Your shopping cart is currently empty
HPPH (Photochlor) (Photochlor) is a second-generation photosensitizer. It is used as photodynamic therapy (PDT) agent.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $60 | In Stock | |
| 2 mg | $88 | In Stock | |
| 5 mg | $147 | In Stock | |
| 10 mg | $263 | In Stock | |
| 25 mg | $455 | In Stock | |
| 50 mg | Preferential | In Stock | |
| 1 mL x 10 mM (in DMSO) | $197 | In Stock |
| Description | HPPH (Photochlor) (Photochlor) is a second-generation photosensitizer. It is used as photodynamic therapy (PDT) agent. |
| In vitro | Cells treated with GO-PEG-HHPH displays a stronger fluorescence signal than those treated with free HPPH. In fact, the fluorescence of HPPH is rather weak. After 24 h, Fluorescence image of 4T1 cells incubated with 0.49 μg/mL GO-PEG, 1 μM HPPH (free HPPH), or equivalent amount of GO-PEG-HPPH (1 μM HPPH and 0.49 μg/mL GO-PEG). The cellular uptake of GO-PEG-HPPH and HPPH is investigated with 4T1 murine mammary cancer cells. The cells are incubated with GO-PEG-HPPH and free HPPH at equivalent HPPH concentration (1 μM) for 24 h and then observed with a confocal microscope [1]. |
| In vivo | A combination treatment regimen for Colo26-HA tumor-bearing BALB/c mice involves administering an HPPH-PDT (0.4 μmoles/kg HPPH followed by 665 nm light at 48 J/cm2) to enhance anti-tumor immunity. Following a 9-day rest period and an HPPH injection, tumors receive a control treatment with 665 nm light at 132 J/cm2 on day 10 [2]. |
| Synonyms | Photochlor |
| Molecular Weight | 636.82 |
| Formula | C39H48N4O4 |
| Cas No. | 149402-51-7 |
| Smiles | CCCCCCOC(C)c1c(C)c2\C=C3/N=C([C@@H](CCC(O)=O)[C@@H]3C)C3=C4NC(\C=c5/[nH]\c(=C/c1[nH]2)c(C)c5CC)C(C)=C4C(=O)C3 |
| Relative Density. | 1.184 g/cm3 |
| Color | Black |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (78.52 mM), Sonication is recommended. H2O: < 0.1 mg/mL (insoluble) | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.14 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.